MedTrace Logo

North American Acute Coronary Syndrome (ACS) Reflective III Pilot

NCT03994575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 248

Last updated 2021-07-27

No results posted yet for this study

Summary

The North American ACS Reflective III Pilot is an observational, Quality Enhancement Research Initiative (QuERI), knowledge translation program designed to give feedback to physicians on their post-ACS lipid-lowering management in an effort to support their decision-making and choice of therapies and thereby better achieve evidence-based, guideline-recommended management of post-ACS patients. The ACS Reflective III Pilot follows the completed ACS Registries I, II, and III, ACS Reflective I, and the ongoing ACS Reflective II programs.

Conditions

  • Dyslipidemias
  • Acute Coronary Syndrome

Interventions

OTHER

Guideline recommended feedback

The ACS Reflective III Pilot program is a quality assurance program where the decision to follow the recommendations and all treatment decisions related to patient care are left to the physician's discretion and feedback to the physician with their aggregate and individual patient data is intended as a quality assurance undertaking

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Canadian Heart Research Centre

    lead OTHER

Principal Investigators

  • Shaun G Goodman, MD, MSc · Co-Chair, Canadian Heart Research Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-15
Primary Completion
2021-05-01
Completion
2021-05-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03994575 on ClinicalTrials.gov